MicroPort Endovascular MedTech Ltd (688016) — Capital Reinvestment Ratio
MicroPort Endovascular MedTech Ltd (688016) has a Capital Reinvestment Ratio of 1.84x as of September 2025, meaning it reinvests 2% of its operating cash flow (CN¥46.79 Million) in capital expenditures (CN¥86.03 Million). Check 688016 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
MicroPort Endovascular MedTech Ltd Capital Reinvestment Ratio (2016–2025)
This chart tracks MicroPort Endovascular MedTech Ltd's Capital Reinvestment Ratio across 10 annual periods. For the full cash flow conversion analysis, see 688016 cash flow metrics.
Annual Capital Reinvestment Ratio for MicroPort Endovascular MedTech Ltd (2016–2025)
Year-by-year Capital Reinvestment Ratio for MicroPort Endovascular MedTech Ltd from 2016 to 2025. See 688016 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.53x | CN¥573.06 Million | CN¥303.03 Million | ▼ -7.1% |
| 2024 | 0.57x | CN¥373.60 Million | CN¥212.65 Million | ▲ +70.9% |
| 2023 | 0.33x | CN¥571.22 Million | CN¥190.26 Million | ▼ -62.2% |
| 2022 | 0.88x | CN¥333.76 Million | CN¥293.98 Million | ▲ +195.2% |
| 2021 | 0.30x | CN¥300.25 Million | CN¥89.58 Million | ▲ +147.4% |
| 2020 | 0.12x | CN¥217.44 Million | CN¥26.22 Million | ▼ -18.7% |
| 2019 | 0.15x | CN¥143.20 Million | CN¥21.24 Million | ▼ -36.4% |
| 2018 | 0.23x | CN¥106.85 Million | CN¥24.90 Million | ▼ -42.7% |
| 2017 | 0.41x | CN¥69.36 Million | CN¥28.23 Million | ▼ -61.4% |
| 2016 | 1.06x | CN¥30.13 Million | CN¥31.81 Million | — |